Insufficient scRNA-seq data for expression of CITED1 at single-cell level.
Insufficient scRNA-seq data for expression of CITED1 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
thymus | 94% | 196.49 | 616 / 653 | 71% | 7.76 | 428 / 605 |
brain | 95% | 350.90 | 2506 / 2642 | 27% | 0.80 | 188 / 705 |
eye | 0% | 0 | 0 / 0 | 100% | 31.27 | 80 / 80 |
prostate | 91% | 313.51 | 222 / 245 | 9% | 0.19 | 45 / 502 |
breast | 82% | 213.61 | 378 / 459 | 4% | 0.09 | 44 / 1118 |
uterus | 51% | 67.02 | 87 / 170 | 2% | 0.05 | 11 / 459 |
kidney | 49% | 103.69 | 44 / 89 | 0% | 0.00 | 2 / 901 |
adrenal gland | 43% | 105.80 | 110 / 258 | 6% | 0.28 | 14 / 230 |
ovary | 44% | 31.08 | 79 / 180 | 2% | 0.04 | 7 / 430 |
esophagus | 44% | 29.43 | 629 / 1445 | 1% | 0.01 | 1 / 183 |
adipose | 43% | 38.06 | 517 / 1204 | 0% | 0 | 0 / 0 |
skin | 4% | 3.19 | 67 / 1809 | 38% | 1.17 | 178 / 472 |
intestine | 30% | 14.08 | 287 / 966 | 4% | 0.06 | 21 / 527 |
pancreas | 20% | 8.20 | 66 / 328 | 1% | 0.02 | 2 / 178 |
stomach | 16% | 11.54 | 56 / 359 | 2% | 0.05 | 7 / 286 |
lung | 13% | 7.00 | 74 / 578 | 1% | 0.01 | 7 / 1155 |
blood vessel | 13% | 6.75 | 171 / 1335 | 0% | 0 | 0 / 0 |
bladder | 5% | 1.48 | 1 / 21 | 2% | 0.04 | 8 / 504 |
heart | 5% | 3.20 | 39 / 861 | 0% | 0 | 0 / 0 |
spleen | 2% | 1.02 | 6 / 241 | 0% | 0 | 0 / 0 |
liver | 1% | 1.75 | 2 / 226 | 0% | 0.00 | 1 / 406 |
muscle | 1% | 0.79 | 7 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 0.06 | 2 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0030511 | Biological process | positive regulation of transforming growth factor beta receptor signaling pathway |
GO_0071107 | Biological process | response to parathyroid hormone |
GO_0060231 | Biological process | mesenchymal to epithelial transition |
GO_0001658 | Biological process | branching involved in ureteric bud morphogenesis |
GO_0043627 | Biological process | response to estrogen |
GO_0034097 | Biological process | response to cytokine |
GO_0042438 | Biological process | melanin biosynthetic process |
GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
GO_0001656 | Biological process | metanephros development |
GO_0010628 | Biological process | positive regulation of gene expression |
GO_0032868 | Biological process | response to insulin |
GO_0001570 | Biological process | vasculogenesis |
GO_0071104 | Biological process | response to interleukin-9 |
GO_0071559 | Biological process | response to transforming growth factor beta |
GO_0070555 | Biological process | response to interleukin-1 |
GO_1902462 | Biological process | positive regulation of mesenchymal stem cell proliferation |
GO_0034341 | Biological process | response to type II interferon |
GO_0001890 | Biological process | placenta development |
GO_0071105 | Biological process | response to interleukin-11 |
GO_0030178 | Biological process | negative regulation of Wnt signaling pathway |
GO_0070741 | Biological process | response to interleukin-6 |
GO_0060395 | Biological process | SMAD protein signal transduction |
GO_0051591 | Biological process | response to cAMP |
GO_0042981 | Biological process | regulation of apoptotic process |
GO_0030318 | Biological process | melanocyte differentiation |
GO_0060711 | Biological process | labyrinthine layer development |
GO_0045893 | Biological process | positive regulation of DNA-templated transcription |
GO_0070669 | Biological process | response to interleukin-2 |
GO_0043473 | Biological process | pigmentation |
GO_0045668 | Biological process | negative regulation of osteoblast differentiation |
GO_0070670 | Biological process | response to interleukin-4 |
GO_0006913 | Biological process | nucleocytoplasmic transport |
GO_0007420 | Biological process | brain development |
GO_0006915 | Biological process | apoptotic process |
GO_0043524 | Biological process | negative regulation of neuron apoptotic process |
GO_0007179 | Biological process | transforming growth factor beta receptor signaling pathway |
GO_0045892 | Biological process | negative regulation of DNA-templated transcription |
GO_0032496 | Biological process | response to lipopolysaccharide |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005829 | Cellular component | cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0042803 | Molecular function | protein homodimerization activity |
GO_0050693 | Molecular function | LBD domain binding |
GO_0003682 | Molecular function | chromatin binding |
GO_0070410 | Molecular function | co-SMAD binding |
GO_0003713 | Molecular function | transcription coactivator activity |
GO_0005515 | Molecular function | protein binding |
Gene name | CITED1 |
Protein name | Cbp/p300 interacting transactivator with Glu/Asp rich carboxy-terminal domain 1 Cbp/p300-interacting transactivator 1 (Melanocyte-specific protein 1) |
Synonyms | MSG1 |
Description | FUNCTION: Transcriptional coactivator of the p300/CBP-mediated transcription complex. Enhances SMAD-mediated transcription by strengthening the functional link between the DNA-binding SMAD transcription factors and the p300/CBP transcription coactivator complex. Stimulates estrogen-dependent transactivation activity mediated by estrogen receptors signaling; stabilizes the interaction of estrogen receptor ESR1 and histone acetyltransferase EP300. Positively regulates TGF-beta signaling through its association with the SMAD/p300/CBP-mediated transcriptional coactivator complex. Induces transcription from estrogen-responsive promoters and protection against cell death. Potentiates EGR2-mediated transcriptional activation activity from the ERBB2 promoter. Acts as an inhibitor of osteoblastic mineralization through a cAMP-dependent parathyroid hormone receptor signaling. May play a role in pigmentation of melanocytes. Associates with chromatin to the estrogen-responsive TGF-alpha promoter region in a estrogen-dependent manner. . |
Accessions | ENST00000445983.5 [Q99966-1] C9J300 ENST00000651998.1 [Q99966-1] ENST00000429794.1 ENST00000246139.9 [Q99966-1] Q99966 ENST00000373619.7 [Q99966-1] H7C2S6 ENST00000453707.6 [Q99966-2] ENST00000450875.5 ENST00000427412.5 C9J7P8 ENST00000417400.1 ENST00000454225.1 ENST00000431381.5 [Q99966-2] C9JRD8 C9J1P6 |